Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
Champions Oncology, Inc. (CSBR) will report its second quarter financial results for the period ended October 31, 2022, on December 13, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Champions Oncology, Inc. (CSBR) will report its second quarter financial results for the period ended October 31, 2022, on December 13, 2022, after market close. The company specializes in drug discovery through AI-driven pharmaco-pheno-multiomic integration and offers innovative research services to biopharma organizations. A conference call discussing the results will take place at 4:30 PM EST on the same day, with dial-in options available for both domestic and international participants. A replay will be accessible within 72 hours.
Positive
- Champions Oncology is known for its innovative approach in drug discovery.
- The company provides valuable research software and R&D services to biopharma organizations.
Negative
- None.
Details
News Market Reaction – CSBR
The recorded move for CSBR in the trading session of this news was -2.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HACKENSACK, NJ / ACCESSWIRE / December 9, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the second quarter ended October 31, 2022, on Tuesday, December 13, 2022, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 877-545-0523 (Domestic) or 973-528-0016 (International) and enter the access code 541646. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 47307, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.
SOURCE: Champions Oncology, Inc.
View source version on accesswire.com:
https://www.accesswire.com/731165/Champions-Oncology-to-Announce-Second-Quarter-Financial-Results-on-Tuesday-December-13-2022
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.